Significance of immunohistochemistry biomarkers in prediction of malignant transformation of oral lichen planus: A systematic review
Med. oral patol. oral cir. bucal (Internet)
; Med. oral patol. oral cir. bucal (Ed.impr.);27(5): e480-e488, September 01, 2022. graf, tab
Article
en En
| IBECS
| ID: ibc-209816
Biblioteca responsable:
ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Background: Oral lichen planus (OLP) is a chronic inflammatory disorder with increased risk for malignanttransformation. Biomarker validation is a pivotal step in moving newly discovered biomarkers towards clinicalimplementation. We performed a systematic review of studies on biomarkers related to OLP, wherein biomarkershave been described in at least two independent studies. Our aim was to determine whether any of these biomarkers might be promising in predicting the increased risk of malignant transformation of OLP.Material and Methods: We searched the following databases until August 2021: PUBMED, EMBASE, and Web ofScience. Due to high heterogeneity, a qualitative rather than quantitative assessment was conducted. Only proteinsthat consistently showed a significantly high level of expression in neoplastic tissues versus OLP in two or morepublications were considered as promising markers.Results: Initial database researches identified 1671, of which 24 articles were included in the final analysis. Themost frequently reported proteins were p53, Bcl-2 and Ki-67, though there were controversies. PCNA and P21were the only proteins that showed consistent evidence of clinical usefulness as cancer predictors to be consideredas promising markers. Extensive methodological variations in the evaluation of expressions and statistical analyses of the included markers were observed, which hampered comparisons of the results. Conclusions: Multiple levels of heterogeneity with a scarcity of high-quality studies were identified. PCNA and P21were identified as promising predictive markers for evaluating the risk of malignant transformation of OLP, but theyrequire further validation. The focus of future research on validation of predictive biomarkers of OLP should be considered as a high priority because it will accelerate the introduction of newly discovered markers into the clinical setting. (AU)
Palabras clave
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Neoplasias de la Boca
/
Inmunohistoquímica
/
Biomarcadores
/
Transformación Celular Neoplásica
/
Liquen Plano Oral
/
Antígeno Nuclear de Célula en Proliferación
Límite:
Humans
Idioma:
En
Revista:
Med. oral patol. oral cir. bucal (Ed.impr.)
/
Med. oral patol. oral cir. bucal (Internet)
Año:
2022
Tipo del documento:
Article